1. "Katherine Panageas"
  2. "Behavioral Sciences Service"
Formats
  1. Journal Article (14)
  2. Meeting Abstract (3)
  3. Research Letter (2)
Groups
  1. Behavioral Sciences Service (19)
  2. Biostatistics Service (19)
  3. Epidemiology and Biostatistics (19)
  4. Population Sciences Research Program (19)
  5. Psychiatry and Behavioral Sciences, Department of (19)
  6. Department of Medicine (18)

More Groups

People
  1. Katherine Panageas (19)
  2. Teresa Gilewski (13)
  3. Clifford Hudis (11)
  4. Larry Norton (11)
  5. Mary Ellen Moynahan (8)
  6. Andrew Seidman (7)

More People

Years
  1. 2023 (2)
  2. 2022 (1)
  3. 2020 (1)
  4. 2019 (1)
  5. 2013 (1)
  6. 2011 (1)

More Years

Publications
  1. Clinical Cancer Research (4)
  2. Journal of Clinical Oncology (4)
  3. Blood Advances (2)
  4. Breast Cancer Research and Treatment (2)
  5. Clinical Breast Cancer (1)
  6. Haematologica (1)

More Publications

Publishers
  1. American Association for Cancer Research (4)
  2. American Society of Clinical Oncology (4)
  3. American Society of Hematology (2)
  4. Elsevier Inc. (2)
  5. John Wiley & Sons (2)
  6. Springer (2)

More Publishers

Results (19)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Dyadic communication in rare cancer: A registry-based study of patients with Erdheim-Chester disease and their caregivers
    Research Letter

    Reiner, A. S.; Applebaum, A. J.; Bossert, D.; Buthorn, J. J.; Sigler, A. M.; Fournier, D.; Brewer, K.; Atkinson, T. M.; Lynch, K. A.; Gilliland, J.; more...
    Blood Advances (2023)

    Fulltext@MSK | Save
  • Patient-reported fatigue and pain in Erdheim-Chester disease: A registry-based, mixed methods study
    Research Letter

    Reiner, A. S.; Bossert, D.; Buthorn, J. J.; Sigler, A. M.; Gonen, S.; Fournier, D.; Brewer, K.; Corkran, J.; Goyal, G.; Allen, C. E.; more...
    Haematologica (2023)

    Fulltext@MSK | Save
  • Challenges and positive impact of rare cancer caregiving: A mixed-methods study of caregivers of patients with Erdheim-Chester disease and other histiocytic neoplasms: Challenges and positive impact in histiocytic neoplasm caregivers
    Journal Article

    Mitchell, H. R.; Applebaum, A. J.; Lynch, K. A.; Reiner, A. S.; Atkinson, T. M.; Buthorn, J. J.; Sigler, A. S.; Bossert, D.; Brewer, K.; Corkran, J.; more...
    eClinicalMedicine (2022)

    Fulltext@MSK | Save
  • The unique burden of rare cancer caregiving: Caregivers of patients with Erdheim–Chester disease
    Journal Article

    Applebaum, A. J.; Polacek, L. C.; Walsh, L.; Reiner, A. S.; Lynch, K.; Benvengo, S.; Buthorn, J.; Atkinson, T. M.; Mao, J. J.; Panageas, K. S.; more...
    Leukemia and Lymphoma (2020)

    Fulltext@MSK | Save
  • A scale for patient-reported symptom assessment for patients with Erdheim-Chester disease
    Journal Article

    Diamond, E. L.; Reiner, A. S.; Buthorn, J. J.; Shuk, E.; Applebaum, A. J.; Hyman, D. M.; Abdel-Wahab, O.; Rampal, R.; Janku, F.; Brewer, K.; more...
    Blood Advances (2019)

    Fulltext@MSK | Save
  • Melanoma survivors: Health behaviors, surveillance, psychosocial factors, and family concerns
    Journal Article

    Oliveria, S. A.; Shuk, E.; Hay, J. L.; Heneghan, M.; Goulart, J. M.; Panageas, K.; Geller, A. C.; Halpern, A. C.
    Psycho-Oncology (2013)

    Fulltext@MSK | Save
  • A pilot study of vaccination with sialyl Lewis(a) (sLe(a))-keyhole limpet hemocyanin (KLH) conjugate plus the immunologic adjuvant QS-21 in metastatic breast cancer patients (pts)
    Meeting Abstract

    Diab, A.; Ragupathi, G.; Scholz, W. W.; Panageas, K.; Hudis, C.; Livingston, P. O.; Gilewski, T.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • A phase II trial of erlotinib in combination with bevacizumab in patients with metastatic breast cancer
    Journal Article

    Dickler, M. N.; Rugo, H. S.; Eberle, C.; Brogi, E.; Caravelli, J.; Panageas, K. S.; Boyd, J.; Yeh, B.; Lake, D. E.; Dang, C.; more...
    Clinical Cancer Research (2008)

    Fulltext@MSK | Save
  • The safety of dose-dense doxorubicin and cyclophosphamide followed by paclitaxel with trastuzumab in HER-2/neu overexpressed/amplified breast cancer
    Journal Article

    Dang, C.; Fornier, M.; Sugarman, S.; Troso-Sandoval, T.; Lake, D.; D'Andrea, G.; Seidman, A.; Sklarin, N.; Dickler, M.; Currie, V.; more...
    Journal of Clinical Oncology (2008)

    Fulltext@MSK | Save
  • Prolonged dose-dense epirubicin and cyclophosphamide followed by paclitaxel in breast cancer is feasible
    Journal Article

    Dang, C.; D'Andrea, G.; Lake, D.; Sugarman, S.; Fornier, M.; Moynahan, M. E.; Gilewski, T.; Hurria, A.; Mills, N.; Troso-Sandoval, T.; more...
    Clinical Breast Cancer (2008)

    Fulltext@MSK | Save